David Roush Email & Phone Number

Experienced Distinguished Scientist with a demonstrated history of working in the pharmaceutical and biotechnology industry. Strong research professional skilled in Vaccines, Biotechnology, Life Sciences, Technology Transfer, Viral Clearance, Commercialization of Biologics and Computational Biophysics.Recent publications include: "Proceedings of the 2023 Viral Clearance Symposium" PDA Journal of Pharmaceutical Science and Technology 2024 (Vol. 78, Issue 2: https://journal.pda.org/content/78/2)"Insulin purification—Innovation continuum via synthesis of fundamentals, technology, and modeling"Biotechnology and Bioengineering 2023 https://doi.org/10.1002/bit.28427."Scale-up issues for commercial depth filters in bioprocessing" Biotechnology and Bioengineering, 2022 https://doi.org/10.1002/bit.28035"Opportunities and Challenges for Model Utilization in the Biopharmaceutical Industry: current vs. future state" Current Opinion in Chemical Engineering 2022 https://doi.org.10.1016/coche.2022.1008.13"The measurement and control of high-risk host cell proteins for polysorbate degradation in biologics formulation” Antibody Therapeutics, Volume 5, Issue 1, January 2022, Pages 42–54, https://doi.org/10.1093/abt/tbac002"Toward in silico CMC: An industrial collaborative approach to model-based process development"Biotechnology and Bioengineering 2020 https://doi.org/10.1002/bit.27520."Retrospective evaluation of cycled resin in viral clearance studies - A multiple company collaboration" (PDA Journal of Science and Technology 2019 10.5731/pdajpst.2018.009605)"Integrated viral clearance strategies — reflecting on the present, projecting to the future", David Roush (Current Opinion in Biotechnology 2018, 53:137–143)"Domain contributions to antibody retention in multimodal chromatography systems" Julie Robinson, David Roush, Steve Cramer (J. Chromatography A 1563 (2018) 89–98)

Listed skills include Technology Transfer, Biotechnology, Chromatography, Life Sciences, and 13 others.